A Locally Invasive Giant Cell Tumor of the Skull Base: Case Report

Abstract

Giant cell tumors (GCTs) are rare, usually affecting the epiphyses in long bones of the extremities. They seldom occur in the skull, where they preferentially affect the sphenoid and temporal bones. Considered to be benign, locally aggressive lesions, they may cause cranial nerve deficits by compression but infrequently invade the dura and parenchyma of the brain. Several case reports with follow-up describe gross total resection of skull base GCT to be curative. Anything short of total resection usually results in recurrence within 4 years. Radiation therapy, although controversial, is reserved for lesions that cannot be completely resected. Some argue, however, against the use of radiation because there are reported cases of malignant transformation. Here we describe the case of a large GCT that was invasive to the dura, temporal lobe, as well as the third division of the trigeminal nerve, and to date gross total resection has been curative of this lesion. The patient has not undergone radiation therapy.

Keywords

giant cell tumors - GCT - epiphyses - extremities - temporal bone - skull base tumor - radiotherapy

• References

• 1 Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumor of the skull. Cancer 1992; 70 (5) 1124-1132
• 2 Wolfe III JT, Scheithauer BW, Dahlin DC. Giant-cell tumor of the sphenoid bone. Review of 10 cases. J Neurosurg 1983; 59 (2) 322-327
• 3 Isaacson B, Berryhill W, Arts HA. Giant-cell tumors of the temporal bone: management strategies. Skull Base 2009; 19 (4) 291-301
• 4 Morriss-Kay GM. Derivation of the mammalian skull vault. J Anat 2001; 199 (Pt 1–2) 143-151
• 5 Wülling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumor of bone. J Cancer Res Clin Oncol 2001; 127 (8) 467-474
• 6 Harris AE, Beckner ME, Barnes L, Kassam A, Horowitz M. Giant cell tumor of the skull: a case report and review of the literature. Surg Neurol 2004; 61 (3) 274-277
• 7 Sanerkin NG. Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 1980; 46 (7) 1641-1649
• 8 Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skeletal Radiol 1997; 26 (4) 246-255
• 9 Dahlin DC. Caldwell Lecture. Giant cell tumor of bone: highlights of 407 cases. AJR Am J Roentgenol 1985; 144 (5) 955-960
• 10 Lee HJ, Lum C. Giant-cell tumor of the skull base. Neuroradiology 1999; 41 (4) 305-307
• 11 Ueda Y, Imai K, Tsuchiya H , et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol 1996; 148 (2) 611-622
• 12 Findlay JM, Chiasson D, Hudson AR, Chui M. Giant-cell tumor of the middle cranial fossa. Case report. J Neurosurg 1987; 66 (6) 924-928
• 13 Ohaegbulam SC, Gupta IM. Giant cell tumour of the sphenoid bone with dural extension. J Neurol Neurosurg Psychiatry 1977; 40 (8) 790-794
• 14 Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 1970; 52 (4) 619-664
• 15 Dahlin DC, Cupps RE, Johnson Jr EW. Giant-cell tumor: a study of 195 cases. Cancer 1970; 25 (5) 1061-1070
• 16 Seider MJ, Rich TA, Ayala AG, Murray JA. Giant cell tumors of bone: treatment with radiation therapy. Radiology 1986; 161 (2) 537-540
• 17 Malone S, O'Sullivan B, Catton C, Bell R, Fornasier V, Davis A. Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys 1995; 33 (3) 689-694
• 18 Glasscock III ME, Hunt WE. Giant-cell tumor of the sphenoid and temporal bones. Laryngoscope 1974; 84 (7) 1181-1187